Table 2.
Frequency of MMP-9 (–1562 C/T) genotype in the patients with pituitary adenoma (PA) and in the control group.
| Gene marker | Genotype/allele | Frequency (%) | ||||
|---|---|---|---|---|---|---|
| Control group n (%) (n = 526) |
p
HWE |
PA group n (%) (n = 86) |
p
HWE |
p value | ||
| MMP-9 (–1562) Rs3918242 | Genotype | |||||
| C/C | 340(64.6)∗ | 0.469 | 70(81.4)∗ | 0.0029 |
X
2 = 11.788 p = 0.003 |
|
| C/T | 169(32.1)∗∗ | 12(14.0)∗∗ | ||||
| T/T | 17 (3.2) | 4 (4.7) | ||||
| Total | 526 (100) | 86 (100) | ||||
| Allele | ||||||
| C | 849 (80.70) | 152 (88.37) | ||||
| T | 203 (19.30) | 20 (11.63) | ||||
MMP, matrix metalloproteinase; p value, significance level (alpha = 0.05); p value HWE, significance level (alpha = 0.05) by Hardy-Weinberg equilibrium.
∗ p = 0.002.
∗∗ p < 0.001.